Tetranectin is a potential biomarker in cerebrospinal fluid and serum of patients with epilepsy

This publication has 30 references indexed in Scilit:

• Impaired cutaneous wound healing in mice lacking tetranectin
  Wound Repair and Regeneration, 2009
• Tetranectin Binds to the Kringle 1‐4 Form of Angiostatin and Modifies Its Functional Activity
  BioMed Research International, 2004
• Mice with a Targeted Deletion of the Tetranectin Gene Exhibit a Spinal Deformity
  Molecular and Cellular Biology, 2001
• Tetranectin Is a Novel Marker for Myogenesis during Embryonic Development, Muscle Regeneration, and Muscle Cell Differentiationin Vitro
  Developmental Biology, 1998
• Tetranectin, a trimeric plasminogen‐binding C‐type lectin
  Protein Science, 1997
• TETRANECTIN AND PLASMIN/PLASMINOGEN ARE SIMILARLY DISTRIBUTED AT THE INVASIVE FRONT OF CUTANEOUS MELANOMA LESIONS
  The Journal of Pathology, 1996
• Transforming growth factor‐β₁ downregulates dexamethasone‐indunced tetranectin gene expression during the in vitro mineralization of the human osteoblastic cell line SV‐HFO
  FEBS Letters, 1995
• The gene structure of tetranectin, a plasminogen binding protein
  FEBS Letters, 1992
• Tetranectin immunoreactivity in normal human tissues
  Histochemistry and Cell Biology, 1989
• Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin
  European Journal of Biochemistry, 1986